AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Assess Before You Release: Monitor CAF DVT
Patients with chronic asymptomatic femoral deep vein thrombosis (CAF DVT) present a lower risk of embolization. However, monitoring is essential as about 30% may experience clot progression. Options include anticoagulation treatment for three months with reassessment or, if there's a high bleeding risk or patient preference against treatment, conducting ultrasounds for monitoring. Two consecutive ultrasounds, five to seven days apart, indicating no progression, allows for the safe cessation of follow-up, alleviating the need for anticoagulation while ensuring patient safety through surveillance.